Financial Reports Latest Updates Industry Maps Economic Calendar

NRC HEALTH (NRC) Annual Reports

Q: Where can I read NRC HEALTH (NRC) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

NRC HEALTH is listed on Nasdaq, classified by the SEC under Services-Commercial Physical & Biological Research (SIC 8731). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 70487 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$35.4M	$34.0M	+4.0%
Operating income	$-3.2M	$1.6M	-303.9%
Net income	$-3.3M	$-106,000	-2997.2%
EPS (diluted)	$-0.15	$-0.01	-1400.0%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 35.4 mn Net income -3.28 mn

Show table：Income statement

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	57.7	14.1	16.0	15.9	19.8	18.3	18.6	19.1	22.4	20.6	21.4	22.0	24.9	22.4	22.4	22.9	26.0	24.0	23.7	25.1	26.3	24.5	25.2	26.4	27.9	26.1	27.0	28.4	30.3	28.4	28.9	29.9	31.0	28.0	30.0	30.6	31.5	31.4	32.5	32.6	33.9	31.2	33.5	34.8	35.5	36.4	37.8	38.3	38.4	37.3	37.7	38.1	36.5	36.2	38.0	38.0	35.3	35.0	35.8	36.9	33.5	34.0	34.6	35.2	34.8	35.4
Operating income	13.7	2.66	3.49	2.36	5.70	3.83	4.19	5.01	6.08	5.22	5.65	5.77	7.22	5.53	6.03	6.03	8.40	6.32	7.16	6.42	5.83	6.36	6.55	7.71	8.01	7.02	7.34	8.83	9.98	8.45	7.12	8.66	8.96	7.76	9.17	9.40	10.7	10.2	10.2	12.0	11.2	9.28	12.0	10.2	12.0	12.2	13.1	12.9	11.7	11.5	11.1	12.2	9.02	9.37	9.96	11.7	8.76	8.87	7.98	9.59	8.60	1.59	7.74	4.67	5.57	-3.24
Net income	8.49	1.66	2.14	1.57	3.46	2.33	2.65	3.13	3.85	3.94	3.58	3.70	4.47	3.43	3.81	3.77	5.45	4.05	4.55	4.10	3.48	4.06	4.14	5.93	5.17	4.56	4.73	5.73	6.52	5.75	4.15	6.52	7.31	7.95	6.99	7.80	8.20	7.39	8.12	8.70	11.8	7.72	9.58	8.21	9.23	8.94	9.66	9.63	8.54	8.32	8.30	6.64	6.96	7.27	7.88	8.86	6.36	6.18	5.69	6.56	5.79	-0.11	4.12	1.80	3.22	-3.28

Balance sheet

Quarterly · In mn (USD)

Total assets 136 mn Total liabilities 130 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	17.3	—	20.9	21.6	22.1	25.3	28.2	32.5	23.8	27.9	29.7	34.9	36.5	42.3	47.5	53.2	53.2	53.2	55.8	56.1	56.1	44.8	42.7	45.9	47.1	52.4	51.0	53.8	52.3	52.3	23.6	28.8	28.4	22.9	22.9	26.6	29.2	34.9	36.7	47.4	54.1	62.2	67.6	72.7	73.7	68.9	51.8	49.1	43.7	45.2	41.0	24.7	24.4	20.0	16.9	20.7	19.6	20.4	25.3	20.4	20.2	20.0	22.8
Total assets	—	—	—	95.8	—	100	101	101	103	106	109	100	104	105	110	111	116	122	127	130	128	131	129	129	118	117	119	121	126	125	129	127	131	103	109	108	105	104	108	111	116	117	127	133	147	152	156	158	153	136	135	130	134	134	120	122	121	119	132	133	135	141	136	135	135	136
Current liabilities	—	—	—	26.1	—	27.1	26.7	24.4	24.4	25.3	37.7	35.3	35.8	24.7	26.1	23.7	23.9	25.3	27.0	27.9	27.6	29.3	31.6	44.2	32.5	29.3	31.1	31.5	34.4	30.9	34.2	32.3	29.5	32.9	35.4	47.1	39.2	37.1	38.3	38.2	39.9	32.3	32.1	31.7	36.9	40.0	39.2	40.4	41.6	39.6	41.1	33.4	36.1	33.7	40.8	36.2	48.9	45.7	44.3	35.9	37.8	35.9	38.6	36.6	38.5	35.0
Total liabilities	—	—	—	47.2	—	47.8	47.4	45.1	45.0	44.5	45.4	43.3	43.6	41.7	42.4	39.2	39.0	39.8	40.8	41.8	40.6	41.4	42.9	54.9	42.2	36.8	38.1	37.8	40.5	36.8	39.9	37.3	35.6	76.1	78.6	89.0	81.8	78.3	78.7	77.8	78.6	71.2	70.5	69.1	73.6	75.5	73.1	72.2	71.7	67.6	67.2	58.4	59.6	55.9	62.3	73.5	84.0	78.9	97.2	101	106	120	121	121	121	130
Equity	44.2	—	—	48.6	—	52.5	53.5	55.5	58.4	61.1	64.1	56.7	60.0	63.2	67.5	71.8	77.3	82.1	86.3	87.8	87.8	89.7	86.6	74.2	76.2	79.7	81.2	82.8	85.6	87.8	88.8	90.0	95.4	26.8	30.1	19.1	22.7	26.0	29.0	32.9	37.3	45.6	56.7	64.3	73.3	76.4	83.1	85.3	81.5	68.6	67.8	72.0	74.7	77.8	57.9	49.0	37.0	40.2	34.6	31.3	29.7	21.3	14.3	14.0	13.5	6.55

Cash flow

Quarterly · In mn (USD)

Operating 1.39 mn Investing -1.32 mn Financing 0.72 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	13.7	9.15	3.20	2.25	3.88	4.38	6.11	4.12	2.08	5.72	5.79	5.54	3.10	2.87	9.37	3.98	5.16	6.21	9.24	5.58	1.58	7.66	5.54	7.11	4.03	7.19	6.79	8.82	8.14	2.48	10.9	6.61	8.23	10.2	7.55	13.9	7.30	8.81	12.9	11.9	5.52	8.38	10.5	16.2	14.4	11.2	8.70	12.1	8.29	9.82	10.1	8.10	7.75	8.84	9.82	11.7	12.0	6.79	9.42	6.38	6.65	-1.14	13.8	7.18	7.18	1.39
Investing	-3.00	-0.76	-15.8	-0.44	-2.32	-2.98	-1.08	-0.54	-0.63	-0.65	-0.61	-0.46	-0.42	-0.55	-0.59	-0.63	-0.6	-0.82	-0.67	-3.62	-0.76	-0.87	-0.57	0.88	-1.08	-1.13	-0.85	-0.68	-1.42	-0.96	-2.51	-1.22	-1.30	-1.47	-2.08	-1.11	-1.13	-1.15	-1.15	-1.23	-0.59	-0.84	-0.75	-1.55	-4.24	-1.57	-0.99	-1.72	-2.54	-1.34	-3.98	-1.97	-3.20	-4.34	-4.47	-3.77	-4.14	-5.27	-6.43	-4.44	-2.99	-3.01	-3.59	-1.12	-1.83	-1.32
Financing	-9.55	-3.66	8.47	-1.55	-1.85	-0.24	-3.04	-1.76	-1.75	-1.64	-1.52	-11.8	-1.60	-0.53	-0.76	0.06	0.04	-0.59	-0.62	-0.56	-3.13	-3.41	-7.29	-3.03	-20.3	-4.32	-4.06	-3.80	-5.16	-4.86	-4.66	-6.43	-5.85	-37.2	-5.13	-6.30	-16.8	-6.50	-7.26	-5.77	-7.54	-6.03	-0.02	-1.92	-1.43	-4.19	-4.06	-8.48	-12.9	-22.7	-10.5	-9.55	-5.86	-5.72	-24.0	-5.11	-12.8	-2.73	-0.02	-1.16	-5.39	6.92	-13.2	-4.14	-6.94	0.72
Cash at period end	2.51	7.24	3.20	3.52	3.32	4.46	6.22	8.08	7.87	11.2	15.0	8.29	9.23	10.8	18.9	22.1	26.4	31.5	39.1	40.0	37.0	40.6	37.6	42.1	25.4	27.2	28.9	33.0	34.7	31.6	35.8	34.7	35.5	6.70	7.27	13.0	2.64	4.02	8.36	13.5	10.0	12.0	21.9	34.7	43.5	48.9	52.5	54.4	47.3	33.0	28.4	25.0	23.7	22.5	3.83	6.65	1.70	0.49	3.46	4.23	2.50	5.27	2.22	4.14	2.55	3.33

Profitability

Quarterly · %

Operating margin -9.2% Net margin -9.3%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating margin	23.7%	18.8%	21.8%	14.8%	28.8%	20.9%	22.6%	26.2%	27.1%	25.3%	26.4%	26.3%	29.0%	24.8%	26.9%	26.3%	32.3%	26.3%	30.2%	25.6%	22.2%	26.0%	25.9%	29.2%	28.7%	26.9%	27.1%	31.1%	33.0%	29.7%	24.6%	29.0%	28.9%	27.7%	30.5%	30.7%	34.0%	32.3%	31.5%	36.7%	33.1%	29.8%	35.9%	29.3%	33.9%	33.6%	34.8%	33.6%	30.4%	30.8%	29.5%	32.1%	24.7%	25.9%	26.2%	30.8%	24.8%	25.3%	22.3%	26.0%	25.6%	4.7%	22.4%	13.3%	16.0%	-9.2%
Net margin	14.7%	11.7%	13.4%	9.9%	17.5%	12.7%	14.3%	16.4%	17.2%	19.1%	16.7%	16.8%	17.9%	15.4%	17.0%	16.4%	20.9%	16.9%	19.2%	16.3%	13.3%	16.6%	16.4%	22.5%	18.6%	17.4%	17.5%	20.2%	21.5%	20.2%	14.3%	21.8%	23.6%	28.4%	23.3%	25.5%	26.0%	23.5%	25.0%	26.7%	34.7%	24.8%	28.6%	23.6%	26.0%	24.6%	25.6%	25.1%	22.2%	22.3%	22.0%	17.4%	19.1%	20.1%	20.8%	23.3%	18.0%	17.6%	15.9%	17.8%	17.3%	-0.3%	11.9%	5.1%	9.3%	-9.3%

Returns & leverage

Quarterly · %

ROE 42.0% ROA 4.2% Debt ratio 95.2%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	28.5%	—	18.1%	18.7%	22.2%	20.5%	23.9%	24.7%	26.8%	26.5%	24.4%	23.4%	24.1%	24.0%	23.5%	23.2%	22.8%	19.6%	18.9%	18.3%	21.7%	23.5%	23.4%	24.3%	25.7%	26.6%	27.1%	26.1%	26.6%	26.2%	45.2%	48.4%	55.1%	52.4%	115.1%	106.6%	124.7%	119.8%	101.4%	88.1%	76.7%	62.9%	59.0%	51.5%	50.1%	47.5%	49.9%	46.1%	40.4%	38.7%	39.9%	45.8%	51.2%	54.4%	49.6%	58.5%	61.8%	72.7%	58.3%	66.9%	51.3%	41.9%	42.0%
ROA	—	—	—	14.5%	—	9.5%	9.9%	11.8%	11.6%	13.2%	13.8%	15.0%	15.2%	14.4%	14.1%	14.7%	15.0%	15.1%	15.0%	15.1%	13.2%	12.8%	12.3%	13.6%	15.6%	16.0%	16.4%	16.2%	17.6%	18.9%	17.9%	18.5%	18.5%	22.8%	24.2%	25.5%	26.3%	29.3%	29.1%	29.6%	32.6%	32.8%	32.1%	30.5%	26.4%	26.8%	25.4%	25.8%	24.5%	25.1%	23.9%	22.1%	21.0%	21.6%	22.5%	24.5%	23.8%	23.2%	21.5%	19.4%	18.9%	13.8%	12.2%	8.7%	6.7%	4.2%
Debt ratio	—	—	—	49.3%	—	47.6%	47.0%	44.8%	43.5%	42.2%	41.5%	43.3%	42.1%	39.7%	38.5%	35.4%	33.5%	32.6%	32.1%	32.3%	31.6%	31.6%	33.1%	42.5%	35.6%	31.6%	31.9%	31.4%	32.1%	29.5%	31.0%	29.3%	27.2%	73.9%	72.3%	82.3%	78.3%	75.1%	73.1%	70.3%	67.8%	61.0%	55.4%	51.8%	50.1%	49.7%	46.8%	45.8%	46.8%	49.6%	49.8%	44.8%	44.4%	41.8%	51.8%	60.0%	69.4%	66.3%	73.7%	76.4%	78.0%	84.9%	89.5%	89.6%	90.0%	95.2%

EPS

Quarterly · US$

EPS US$-0.15

Show table：EPS

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	1.26	0.25	0.32	0.23	0.51	0.34	0.39	0.46	0.56	0.57	0.51	0.53	0.64	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.32	0.29	0.31	0.34	0.46	0.30	0.37	0.32	0.36	0.35	0.38	0.38	0.34	0.33	0.33	0.27	0.28	0.29	0.32	0.36	0.27	0.26	0.24	0.28	0.25	-0.01	0.18	49.57	0.14	-0.15

Revenue & profit

Year-to-date · In mn (USD)

Revenue 70.2 mn Net income -0.06 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 136 mn Total liabilities 130 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating 8.57 mn Investing -3.16 mn Financing -6.22 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Operating margin 3.3% Net margin -0.1%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE 42.0% ROA 4.2% Debt ratio 95.2%

EPS

Year-to-date · US$

EPS US$-0.01

Revenue & profit

Annual · In mn (USD)

Revenue 137 mn Net income 11.6 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	75.8	86.4	92.6	98.8	102	109	118	120	128	133	148	152	149	143	137
Operating income	18.7	22.7	24.8	28.3	26.4	31.2	34.2	35.3	43.0	42.7	50.3	46.5	40.0	35.2	22.6
Net income	11.6	15.1	15.5	18.2	17.6	20.2	22.9	30.1	32.4	37.3	37.5	31.8	31.0	24.8	11.6

Balance sheet

Annual · In mn (USD)

Total assets 135 mn Total liabilities 121 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	22.1	23.8	36.5	53.2	56.1	47.1	52.3	28.4	29.2	54.1	73.7	43.7	24.4	19.6	20.2
Total assets	101	100	111	130	129	121	127	108	111	133	158	130	122	133	135
Current liabilities	24.4	35.3	23.7	27.9	44.2	31.5	32.3	47.1	38.2	31.7	40.4	33.4	36.2	35.9	36.6
Total liabilities	45.1	43.3	39.2	41.8	54.9	37.8	37.3	89.0	77.8	69.1	72.2	58.4	73.5	101	121
Equity	55.5	56.7	71.8	87.8	74.2	82.8	90.0	19.1	32.9	64.3	85.3	72.0	49.0	31.3	14.0

Cash flow

Annual · In mn (USD)

Operating 26.4 mn Investing -10.7 mn Financing -15.8 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	18.5	19.1	19.3	26.2	21.9	26.8	28.1	39.9	40.9	40.6	46.3	36.3	38.1	34.6	26.4
Investing	-6.93	-2.35	-2.19	-5.72	-1.33	-3.75	-6.12	-5.97	-4.66	-3.72	-8.51	-9.84	-15.8	-20.3	-10.7
Financing	-6.89	-16.7	-2.82	-1.73	-16.9	-32.5	-21.1	-54.5	-36.4	-15.5	-18.2	-55.6	-40.7	-16.8	-15.8
Cash at period end	8.08	8.29	22.1	40.0	42.1	33.0	34.7	13.0	13.5	34.7	54.4	25.0	6.65	4.23	4.14

Profitability

Annual · %

Operating margin 16.4% Net margin 8.4%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating margin	24.7%	26.3%	26.8%	28.6%	25.8%	28.5%	29.1%	29.5%	33.6%	32.0%	34.0%	30.7%	26.9%	24.6%	16.4%
Net margin	15.3%	17.4%	16.7%	18.4%	17.2%	18.4%	19.5%	25.1%	25.3%	28.0%	25.3%	21.0%	20.8%	17.3%	8.4%

Returns & leverage

Annual · %

ROE 51.3% ROA 8.7% Debt ratio 89.6%

Show table：Returns & leverage

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	20.8%	26.8%	24.1%	22.8%	21.7%	25.7%	26.6%	55.1%	124.7%	76.7%	50.1%	40.4%	51.2%	61.8%	51.3%
ROA	11.5%	15.0%	14.7%	15.1%	13.6%	16.2%	18.5%	25.5%	29.6%	30.5%	25.8%	22.1%	24.5%	19.4%	8.7%
Debt ratio	44.8%	43.3%	35.4%	32.3%	42.5%	31.4%	29.3%	82.3%	70.3%	51.8%	45.8%	44.8%	60.0%	76.4%	89.6%

EPS

Annual · US$

EPS US$49.99

Show table：EPS

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	1.70	2.17	—	—	—	—	—	—	1.26	1.45	1.47	1.27	1.25	1.05	49.99

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read NRC HEALTH (NRC) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.